Dr. Ciro Tetta is Managing Director at Unicyte Srl, based in Palazzo Pignano (Cremona, Italy), a subsidary of Unicyte AG, a biotech company focused on regenerative medicine and oncology. With a background in nephrology and internal medicine, he earned his medical degree and specialization in Italy before embarking on a distinguished career in both clinical research and pharmaceutical innovation. Dr. Tetta has held senior positions at Fresenius Medical Care, where he led international R&D programs in dialysis, renal care, and cell therapies. At Unicyte, he oversees the development of novel stem cell-based therapies and extracellular vesicle technologies for the treatment of chronic diseases and cancer. He is known for his translational approach, bridging academic science and industrial development. Dr. Tetta has authored numerous scientific publications and is a recognized expert in nephrology, regenerative biology, and therapeutic innovation. His leadership continues to drive Unicyte’s mission to bring advanced cellular therapies from bench to bedside.